A Study to Assess the Engagement and Usefulness of Care4Today Digital Platform for Disease Management in Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD) Population
- Conditions
- Coronary Artery Disease (CAD)Peripheral Artery Disease (PAD)
- Registration Number
- NCT06052319
- Lead Sponsor
- Janssen Scientific Affairs, LLC
- Brief Summary
The purpose of this study is to assess the engagement and usefulness of Care4Today® Connect CAD-PAD digital platform in participants with coronary artery disease or peripheral artery disease (CAD or PAD).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 277
- Must have a diagnosis of CAD and or PAD, who are on therapy or about to initiate therapy
- Own an iPhone or Android mobile device
- Have an active email account
- Must sign a participation agreement or informed consent form (ICF) allowing data collection in accordance with local requirements
- Willing to download and use Care4Today (C4T) CAD-PAD application (app)
- Any cardiovascular conditions (for example, recent stroke, high bleeding risk, severe heart failure) or non-cardiovascular condition deemed as poor prognosis by the investigator and which may percent a patient from completing the study
- Unable to read or write the language used for the C4T (English, or Spanish if Spanish version is available)
- Visual or hearing impairment or mental disability that would preclude independent app use
- Patients currently using the C4T app prior to the signing of ICF
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of Engaged Participants who Complete End of Study Survey with Satisfaction Response Score of Greater Than or Equal to (>=) 2 for at Least 3 Questions Up to 3 months Percentage of engaged participants who complete end of study survey with satisfaction response score of \>= 2 for at least 3 questions (out of 6 total questions) will be reported. Satisfaction survey consists of six questions in the end of study - each with 5 possible responses on a likert scale (1-5). The lowest possible response to any question is 1 =disagree and the highest possible response to any question is 5 = agree. Higher response on this scale represents more agreement or satisfaction.
Percentage of Participants Who use the Care4Today (C4T) Coronary Artery Disease-Peripheral Artery Disease (CAD-PAD) Application for at Least 10 Weeks During the 3-Month Study Period Up to 3 months Percentage of participants (of those who onboarded the C4T CAD-PAD app) who use CAD-PAD the application for at least 10 weeks during the 3-month study period will be reported. The weekly app use is defined as using at least one component of the app once a week.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (6)
University of Colorado Anschutz Medical Campus
🇺🇸Aurora, Colorado, United States
HCA Florida Memorial Hospital
🇺🇸Jacksonville, Florida, United States
University of Florida Health Jacksonville
🇺🇸Jacksonville, Florida, United States
The Kansas City Heart Rhythm Institute
🇺🇸Overland Park, Kansas, United States
HCA Houston Healthcare Medical Center
🇺🇸Houston, Texas, United States
Rio Grande Regional Hospital
🇺🇸McAllen, Texas, United States
University of Colorado Anschutz Medical Campus🇺🇸Aurora, Colorado, United States